Clinical trials data
Go/No-Go Task in ADHD trials: 65 registered studies
Every registered ADHD study on ClinicalTrials.gov that names the Go/No-Go Task in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered ADHD studies name it in an outcome measure
- 65
- Name it in a primary outcome, 49%
- 32 of 65
Tests named in the same studies
- 1
Continuous Performance Test16 studies, 5 as a primary outcome
- 2
Stop-Signal Task11 studies, 6 as a primary outcome
- 3
Digit Span Test9 studies, 2 as a primary outcome
- 4
AX Continuous Performance Test7 studies, 0 as a primary outcome
- 5
Eriksen Flanker Task6 studies, 3 as a primary outcome
- 6
Stroop Color-Word Test5 studies, 1 as a primary outcome
- 7
Delay Discounting4 studies, 1 as a primary outcome
- 8
Attention Network Test3 studies, 2 as a primary outcome
- 9
N-Back Task3 studies, 2 as a primary outcome
- 10
Affective Go/No-Go3 studies, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 2 | 2 |
| 2010 | 1 | 0 |
| 2011 | 3 | 2 |
| 2012 | 4 | 1 |
| 2013 | 4 | 1 |
| 2014 | 6 | 1 |
| 2015 | 6 | 5 |
| 2016 | 2 | 1 |
| 2017 | 5 | 3 |
| 2018 | 4 | 2 |
| 2019 | 2 | 1 |
| 2020 | 3 | 2 |
| 2021 | 2 | 1 |
| 2022 | 7 | 3 |
| 2023 | 2 | 2 |
| 2024 | 2 | 1 |
| 2025 | 4 | 3 |
| 2026 | 4 | 1 |
Phases and study sizes
By phase
- Early phase 11 studies, 1 as a primary outcome
- Phase 13 studies, 1 as a primary outcome
- Phase 1/22 studies, 0 as a primary outcome
- Phase 22 studies, 1 as a primary outcome
- Phase 32 studies, 1 as a primary outcome
- Phase 49 studies, 6 as a primary outcome
- Not applicable38 studies, 16 as a primary outcome
- Observational8 studies, 6 as a primary outcome
Participants per study
- Not applicable70 median, 30 to 96
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 38 | 70 | 30 to 96 |
When ADHD trials measure it
Latest time point of each outcome
- Within a day9 outcomes, 6 as a primary outcome
- Up to 4 weeks14 outcomes, 5 as a primary outcome
- 1 to 3 months21 outcomes, 10 as a primary outcome
- 3 to 6 months6 outcomes, 3 as a primary outcome
- 6 to 12 months5 outcomes, 2 as a primary outcome
- 1 to 2 years2 outcomes, 1 as a primary outcome
- Over 2 years1 outcomes, 1 as a primary outcome
- No duration given7 outcomes, 4 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
58 of the 65 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting7 studies, 6 as a primary outcome
- Not yet recruiting4 studies, 0 as a primary outcome
- Active, not recruiting2 studies, 1 as a primary outcome
- Completed41 studies, 19 as a primary outcome
- Stopped early1 studies, 1 as a primary outcome
- Status unknown10 studies, 5 as a primary outcome
What they test
- Behavioral22 studies, 8 as a primary outcome
- Drug15 studies, 10 as a primary outcome
- Device14 studies, 6 as a primary outcome
- Dietary supplement4 studies, 2 as a primary outcome
- Procedure1 studies, 1 as a primary outcome
- Diagnostic test1 studies, 1 as a primary outcome
- Combination product1 studies, 1 as a primary outcome
- Other15 studies, 7 as a primary outcome
- None given3 studies, 2 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States34 studies, 18 as a primary outcome
- Brazil5 studies, 1 as a primary outcome
- United Kingdom4 studies, 1 as a primary outcome
- China3 studies, 1 as a primary outcome
- Belgium2 studies, 2 as a primary outcome
- Germany2 studies, 2 as a primary outcome
- Israel2 studies, 1 as a primary outcome
- Sweden2 studies, 1 as a primary outcome
- Canada1 studies, 0 as a primary outcome
- Denmark1 studies, 1 as a primary outcome
- France1 studies, 0 as a primary outcome
- Greece1 studies, 1 as a primary outcome
19 countries in all. A study with sites in several counts in each; 0 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed ADHD studies that name the Go/No-Go Task: 22 of 41, 54%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed ADHD studies that name the Go/No-Go Task | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 5, 12% | 776, 10% |
| Results on ClinicalTrials.gov only | 7, 17% | 1,139, 14% |
| A results paper only | 10, 24% | 1,711, 22% |
| Neither | 19, 46% | 4,327, 54% |
The 65 studies
65 studies match. 32 name the Go/No-Go Task in a primary outcome. Median size 72 participants. Median time to the primary outcome: 8 weeks.
Loading 65 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 2 | 2 |
| 2010 | 1 | 0 |
| 2011 | 3 | 2 |
| 2012 | 4 | 1 |
| 2013 | 4 | 1 |
| 2014 | 6 | 1 |
| 2015 | 6 | 5 |
| 2016 | 2 | 1 |
| 2017 | 5 | 3 |
| 2018 | 4 | 2 |
| 2019 | 2 | 1 |
| 2020 | 3 | 2 |
| 2021 | 2 | 1 |
| 2022 | 7 | 3 |
| 2023 | 2 | 2 |
| 2024 | 2 | 1 |
| 2025 | 4 | 3 |
| 2026 | 4 | 1 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 1, other 64. Interventional 57, observational 8.
As a primary outcomeSecondary or other outcomeThe Go/No-Go Task
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07767617 | Start2026 | PhaseNot applicable | ConditionsADHD, Sleep and sleep disorders | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07650643 | Start2026 | PhasePhase 4 | ConditionsADHD | Participants220 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07442058 | Start2026 | PhaseNot applicable | ConditionsADHD | Participants35 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07318935 | Start2024 | PhaseNot applicable | ConditionsADHD | Participants69 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07228650 | Start2025 | PhaseObservational | ConditionsADHD | Participants500 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07189442 | Start2025 | PhaseNot applicable | ConditionsADHD, Autism | Participants17 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07084649 | Start2025 | PhasePhase 1/2 | ConditionsADHD | Participants15 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07061470 | Start2027 | PhasePhase 1/2 | ConditionsADHD, Sleep and sleep disorders | Participants70 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07037030 | Start2026 | PhaseNot applicable | ConditionsADHD | Participants10 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06810180 | Start2025 | PhaseNot applicable | ConditionsADHD, Aging, frailty and exercise, Sleep and sleep disorders | Participants200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06657469 | Start2017 | PhaseNot applicable | ConditionsADHD | Participants80 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06632249 | Start2024 | PhaseNot applicable | ConditionsADHD | Participants98 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06241300 | Start2023 | PhaseNot applicable | ConditionsADHD | Participants180 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06030024 | Start2021 | PhaseNot applicable | ConditionsADHD | Participants10 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05927506 | Start2015 | PhaseObservational | ConditionsADHD | Participants312 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05668195 | Start2022 | PhaseNot applicable | ConditionsADHD | Participants200 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05650775 | Start2023 | PhasePhase 1 | ConditionsADHD | Participants16 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05582928 | Start2022 | PhaseNot applicable | ConditionsADHD, Healthy volunteers | Participants60 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05391698 | Start2022 | PhaseNot applicable | ConditionsADHD | Participants16 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05374187 | Start2022 | PhaseNot applicable | ConditionsADHD | Participants218 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05308706 | Start2022 | PhaseNot applicable | ConditionsADHD | Participants100 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT05155696 | Start2022 | PhaseNot applicable | ConditionsADHD | Participants81 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05118932 | Start2017 | PhaseNot applicable | ConditionsADHD | Participants196 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05049239 | Start2021 | PhaseNot applicable | ConditionsADHD | Participants75 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT04634006 | Start2020 | PhaseNot applicable | ConditionsADHD | Participants75 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
Questions, answered from the data
How many ADHD trials use the Go/No-Go Task?
65 registered ADHD studies on ClinicalTrials.gov name it in an outcome measure, 32 of them in a primary outcome: 18% of the condition's 357 studies with a cognitive outcome, against 4% of all of them. It is the 2nd most named test in ADHD trials.
Which tests do ADHD trials use with the Go/No-Go Task?
The Continuous Performance Test (16 studies), the Stop-Signal Task (11 studies) and the Digit Span Test (9 studies).
When do ADHD trials measure the Go/No-Go Task?
Half of the primary outcomes that name the Go/No-Go Task are measured within 8 weeks of the start, and the middle half from 6 days to 14 weeks. 28 primary outcomes give a duration.
How many completed ADHD trials that use the Go/No-Go Task have reported results?
22 of the 41 completed studies that name it, 54%, have reported results: 12 posted them on ClinicalTrials.gov, 15 have a results paper linked to the registry record, and 5 did both. The other 19 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Go/No-Go Task and Go/No-Go Game as one test family, so this page counts their studies together.
Run the Go/No-Go Task in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.